Cure8 research brief
Why This Matters
People who undergo EMR may still develop colorectal cancer afterward, and this study suggests incidence differs by age, race, and ethnicity. Those differences could affect how follow-up surveillance is planned and highlight equity concerns.
Who Should Pay Attention
Patients post-EMR, gastroenterologists/endoscopists, surveillance program planners, researchers focused on CRC risk and health disparities
Study Snapshot
What To Know
This study used a large electronic health record network to measure how often colorectal cancer (CRC) was diagnosed after endoscopic mucosal resection (EMR) of complex colorectal lesions between 2016–2021.
The authors report overall incidence rates per 1,000 person-years and highlight differences by age, sex, race, and ethnicity, with higher post-EMR CRC incidence in Hispanic/Latino and Asian patients and an unexpectedly high rate in the 40–49 age group.
The research suggests that CRC can still be diagnosed after EMR and that risk appears to vary across demographic groups. The authors call for risk-stratified, equity-focused surveillance after EMR and prospective studies that combine procedural and molecular data to better understand which patients need closer follow-up.
This brief summarizes the study abstract and does not represent a full review of the full article text or supplemental materials.
Keep In Mind
Findings come from a retrospective EHR cohort (TriNetX) and the article abstract; excluded were patients with IBD or FAP. Results show associations and incidence rates but do not prove causation; prospective research is needed.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.